CISPLATIN REGIMENS AND IMPROVED PROGNOSIS OF PATIENTS WITH POORLY DIFFERENTIATED OVARIAN-CANCER

被引：56

作者：

BRUCKNER, HW

COHEN, CJ

GOLDBERG, JD

KABAKOW, B

WALLACH, RC

DEPPE, G

REISMAN, AZ

GUSBERG, SB

HOLLAND, JF

机构：

[1] CUNY MT SINAI SCH MED,MT SINAI & BETH ISRAEL MED CTR,DEPT NEOPLAST DIS,NEW YORK,NY 10029

[2] CUNY MT SINAI SCH MED,MT SINAI & BETH ISRAEL MED CTR,DEPT OBSTET & GYNECOL,NEW YORK,NY 10029

[3] CUNY MT SINAI SCH MED,MT SINAI & BETH ISRAEL MED CTR,DEPT MED,NEW YORK,NY 10029

来源：

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 1983年 / 145卷 / 06期

关键词：

D O I：

10.1016/0002-9378(83)90569-0

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：653 / 658

页数：6

共 15 条

[1]

BRUCKNER H W, 1977, Journal of Clinical Hematology and Oncology, V7, P619

[2]

BRUCKNER HW, 1981, CANCER, V47, P2288, DOI 10.1002/1097-0142(19810501)47:9<2288::AID-CNCR2820470931>3.0.CO

[3]

2-3

[4] TREATMENT OF CHEMOTHERAPY-RESISTANT ADVANCED OVARIAN-CANCER WITH A COMBINATION OF CYCLOPHOSPHAMIDE, HEXAMETHYLMELAMINE, ADRIAMYCIN, AND CIS-DIAMMINEDICHLOROPLATINUM (CHAP) [J].

BRUCKNER, HW ;

COHEN, CJ ;

DEPPE, G ;

KABAKOW, B ;

WALLACH, R ;

RATNER, L ;

HOLLAND, JF .

GYNECOLOGIC ONCOLOGY, 1981, 12 (02) :150-153

[5]

BRUCKNER HW, 1980, CISPLATIN DERZEITIGE, P141

[6]

BRUCKNER HW, 1982, P AN M AM SOC CLIN, V1, P107

[7]

COHEN CJ, 1981, P AM SOC CLIN ONCOL, V22, P382

[8]

COX DR, 1972, J R STAT SOC B, V34, P187

[9]

GRECO AF, 1981, P AN M AM SOC CLIN, V22, P422

[10]

GRIFFITHS CT, 1980, THERAPEUTIC PROGR OV, P3

← 1 2 →